Amphotericin B-induced sensitivity to actinomycin D in drug-resistant Hela cells. 1975

J Medoff, and G Medoff, and M N Goldstein, and D Schlessinger, and G S Kobayaski

HeLa cells, which were selected for resistance to actinomycin D on the basis of decreaded penetration of the antibiotic into the cells, were treated with nontoxic concentrations of the polyene antibiotic amphotericin B. In the presence of amphotericin B, the cells became sensitive to the effects of actinomycin D, as demonstrated by loss of cell viability, typical morphological changes, and effects on the pattern of RNA synthesis. Furthermore, we were able to demonstrate that amphotericin B increased the amount of (3H)actinomycin D incorporated into HeLa cells as determined by both radioactive counts and radioautography. Amphotericin B might be useful in overcoming the resistance is based on decreased entry of the agents into cells.

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D012334 RNA, Neoplasm RNA present in neoplastic tissue. Neoplasm RNA

Related Publications

J Medoff, and G Medoff, and M N Goldstein, and D Schlessinger, and G S Kobayaski
March 1966, Science (New York, N.Y.),
J Medoff, and G Medoff, and M N Goldstein, and D Schlessinger, and G S Kobayaski
April 1966, Proceedings of the National Academy of Sciences of the United States of America,
J Medoff, and G Medoff, and M N Goldstein, and D Schlessinger, and G S Kobayaski
October 1960, Annals of the New York Academy of Sciences,
J Medoff, and G Medoff, and M N Goldstein, and D Schlessinger, and G S Kobayaski
October 1971, Journal of molecular biology,
J Medoff, and G Medoff, and M N Goldstein, and D Schlessinger, and G S Kobayaski
August 1961, Cancer research,
J Medoff, and G Medoff, and M N Goldstein, and D Schlessinger, and G S Kobayaski
July 1963, Nature,
J Medoff, and G Medoff, and M N Goldstein, and D Schlessinger, and G S Kobayaski
September 1995, Cancer letters,
J Medoff, and G Medoff, and M N Goldstein, and D Schlessinger, and G S Kobayaski
June 1976, Nature,
J Medoff, and G Medoff, and M N Goldstein, and D Schlessinger, and G S Kobayaski
September 1969, The Biochemical journal,
J Medoff, and G Medoff, and M N Goldstein, and D Schlessinger, and G S Kobayaski
April 1963, Biochemical and biophysical research communications,
Copied contents to your clipboard!